CAMBRIDGE, Mass.- June 8, 2009 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced it will provide presentations at two upcoming investor conferences, at the following locations and times:
- 30th Annual Goldman Sachs Global Healthcare Conference, Grand Hyatt Hotel (Hubbard Room) in New York, NY on Monday, June 8th at 3:30 PM EDT. Presentation by Jas Seehra, Ph.D., Chief Scientific Officer, Acceleron Pharma
- 8th Annual Needham Life Sciences Conference, New York Palace Hotel in New York, NY on Wednesday, June 10th at 2:00 PM EDT. Presentation by John Knopf, Ph.D., Chief Executive Officer, Acceleron Pharma
About Acceleron
Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of red blood cells, bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases. Acceleron’s scientific approach takes advantage of its unique insight into the regenerative powers of the TGF-beta superfamily of proteins. ACE-011 is currently being studied in a Phase 2 clinical trial in multiple myeloma patients with osteolytic bone disease. ACE-031 is currently being studied in a Phase 1 clinical trial in healthy volunteers. In addition, the company is advancing new product candidates that increase muscle mass, control angiogenesis, inhibit fat accumulation and increase hemoglobin. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company’s internal GMP manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron include Advanced Technology Ventures, Bessemer Ventures, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. For more information, visit www.acceleronpharma.com.
CONTACT:
Acceleron Pharma:
Steven Ertel, 617-649-9234
Vice President, Corporate Development
Paul Kidwell (Media)
Suda Communications LLC, tel: 617-296-3854